A detailed history of Pure Financial Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 22,021 shares of PFE stock, worth $580,473. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,021
Previous 27,701 20.5%
Holding current value
$580,473
Previous $775,000 17.81%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $157,336 - $178,295
-5,680 Reduced 20.5%
22,021 $637,000
Q2 2024

Jul 18, 2024

SELL
$25.26 - $29.6 $22,582 - $26,462
-894 Reduced 3.13%
27,701 $775,000
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $148,556 - $170,590
5,738 Added 25.1%
28,595 $793,000
Q4 2023

Jan 08, 2024

BUY
$26.13 - $33.94 $16,331 - $21,212
625 Added 2.81%
22,857 $658,000
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $47,974 - $56,077
1,495 Added 7.21%
22,232 $737,000
Q2 2023

Jul 10, 2023

SELL
$36.12 - $41.79 $211,301 - $244,471
-5,850 Reduced 22.0%
20,737 $760,000
Q1 2023

Apr 11, 2023

BUY
$39.39 - $51.28 $52,821 - $68,766
1,341 Added 5.31%
26,587 $1.08 Million
Q4 2022

Jan 09, 2023

SELL
$41.75 - $54.5 $1,628 - $2,125
-39 Reduced 0.15%
25,246 $0
Q3 2022

Oct 06, 2022

BUY
$43.76 - $53.42 $95,440 - $116,509
2,181 Added 9.44%
25,285 $1.11 Million
Q2 2022

Jul 08, 2022

SELL
$46.53 - $55.17 $203,056 - $240,761
-4,364 Reduced 15.89%
23,104 $1.21 Million
Q1 2022

Apr 12, 2022

BUY
$45.75 - $56.69 $43,737 - $54,195
956 Added 3.61%
27,468 $1.42 Million
Q4 2021

Jan 12, 2022

BUY
$41.32 - $61.25 $27,064 - $40,118
655 Added 2.53%
26,512 $1.57 Million
Q3 2021

Oct 07, 2021

BUY
$39.25 - $50.42 $31,596 - $40,588
805 Added 3.21%
25,857 $1.11 Million
Q2 2021

Jul 09, 2021

BUY
$35.91 - $40.68 $430 - $488
12 Added 0.05%
25,052 $981,000
Q1 2021

Apr 09, 2021

BUY
$33.49 - $37.77 $21,433 - $24,172
640 Added 2.62%
25,040 $907,000
Q4 2020

Jan 12, 2021

BUY
$33.47 - $42.56 $4,853 - $6,171
145 Added 0.6%
24,400 $898,000
Q3 2020

Oct 07, 2020

BUY
$31.75 - $37.25 $3,206 - $3,762
101 Added 0.42%
24,255 $890,000
Q2 2020

Jul 08, 2020

BUY
$30.12 - $36.54 $12,048 - $14,616
400 Added 1.68%
24,154 $790,000
Q1 2020

Apr 07, 2020

SELL
$27.03 - $38.62 $39,409 - $56,307
-1,458 Reduced 5.78%
23,754 $775,000
Q4 2019

Jan 09, 2020

BUY
$32.92 - $37.36 $25,085 - $28,468
762 Added 3.12%
25,212 $988,000
Q3 2019

Oct 09, 2019

SELL
$32.49 - $42.13 $170,962 - $221,688
-5,262 Reduced 17.71%
24,450 $878,000
Q2 2019

Jul 11, 2019

BUY
$36.98 - $41.52 $2,588 - $2,906
70 Added 0.24%
29,712 $1.29 Million
Q1 2019

Apr 05, 2019

SELL
$37.5 - $41.2 $27,225 - $29,911
-726 Reduced 2.39%
29,642 $1.26 Million
Q4 2018

Jan 11, 2019

BUY
$38.47 - $43.86 $29,506 - $33,640
767 Added 2.59%
30,368 $1.33 Million
Q3 2018

Oct 04, 2018

BUY
$34.47 - $41.81 $179,795 - $218,080
5,216 Added 21.39%
29,601 $1.3 Million
Q2 2018

Jul 10, 2018

BUY
$32.98 - $35.16 $13,290 - $14,169
403 Added 1.68%
24,385 $885,000
Q1 2018

Apr 05, 2018

BUY
$31.91 - $37.02 $5,105 - $5,923
160 Added 0.67%
23,982 $851,000
Q4 2017

Jan 10, 2018

BUY
$33.26 - $35.29 $26,541 - $28,161
798 Added 3.47%
23,822 $863,000
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $713,744 - $786,269
23,024
23,024 $822,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pure Financial Advisors, LLC Portfolio

Follow Pure Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.